Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04791943 · ClinicalTrials.gov registry record · Phase 2

Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery

A Phase 2 study, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target

NCT04791943: Completed Phase 2 study, sponsored by Montefiore Medical Center.

NCT04791943 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04791943, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target

Study Summary

The purpose of the study is to assess if melatonin given for three nights before wisdom tooth surgery decreases post-operative pain and pain medication consumption. Patients will receive either melatonin or a placebo for three nights prior to surgery.

Primary Outcome

Postoperative consumption of narcotic pain medication will be measured for approximately 72 hours post operatively. Three total surveys will be administered. The surveys will be sent to participants via text message or email and include a link to SurveyMonkey. These surveys will be sent in the morning approximately 1 day, 2 days, and 3 days after surgery. The surveys will query for participant identification and then ask how many tablets of ibuprofen 600mg and hydrocodone-acetaminophen have been

Interventions

  • DRUG Melatonin 10 MG
  • DRUG Lactose pill

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-11-16
Est. Completion 2025-10-20
Phase Phase 2
Montefiore Medical Center

345 total trials

What the finished NCT04791943 record still lists

NCT04791943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).

The record links to 0 conditions, and to 2 interventions - of which Melatonin 10 MG is the first listed.

NCT04791943 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04791943 about?

NCT04791943 is a clinical study titled "Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery". The purpose of the study is to assess if melatonin given for three nights before wisdom tooth surgery decreases post-operative pain and pain medication consumption. Patients will receive either melatonin or a placebo for three nights prior to surgery.

What is the current status of trial NCT04791943?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2021-11-16. Estimated completion is 2025-10-20.

What interventions are being tested in trial NCT04791943?

The interventions under investigation include: Melatonin 10 MG (DRUG), Lactose pill (DRUG).

Who is sponsoring clinical trial NCT04791943?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04791943's enrollment target sits among peer trials

60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04791943, the US trial registry maintained by the National Library of Medicine. NCT04791943 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.